Default company panoramic image

CelaCare Technologies, Inc.

Specialty pharmaceutical company engaged in development of novel antimicrobial topical and oral formulations

  • Stage Product In Development
  • Industry Biotechnology
  • Location Dallas, TX, USA
  • Currency USD
  • Founded September 2011
  • Employees 2
  • Website

Company Summary

CelaCare Technologies, Inc. is an early-stage Harding University spin-out specialty pharmaceutical company. The company is engaged in the development of novel formulations of antimicrobials for mucosal and topical therapy for both human and veterinary markets. The company’s initial products are based on a combination of a proprietary ISO qualified silver citrate complex, an antimicrobial salt with demonstrated potency, and acemannan, a known immunomodulator manufactured in accordance with US FDA current Good Manufacturing Practices. This combination possesses unique synergistic antimicrobial effects allowing for significantly reduced silver concentrations while providing potent activity against fungal pathogens and multi-drug resistant bacterial strains. In addition, formulations possess functional properties for improved tissue repair and pain relief. The company has filed patent applications on this unique combination thus providing foundational protection for a planned portfolio of products.


  • Bcbe5504 7423 45d5 9fd9 4641bb0d1f3f
    President and CEO

    Dr. Kenneth Yates serves as president and CEO. He has more than 25 years of industry experience spanning R&D and management, including significant experience in wound and oral care product development. Dr. Yates previously served as president of DelSite Biotechnologies and currently is chair of the department of pharmaceutical sciences at Harding University College of Pharmacy. Dr. Yates also is a director for Piedmont Pharmaceuticals, LLC.

  • D4fbe722 d5f3 4463 a307 26cdb4b8c891
    Vice President Specialty Pharmacy and Clinical Affairs

    Dr. Ginger Lowrie has served in various clinical, research, and pharmaceutical areas over the past 25 years. She has served as a Heme/Onc medical science liasion for GlaxoSmithKline and support for investigator sponsored trials. Dr. Lowrie has 17+ years of Pharmacy experience where she opened and consulted for multiple ambulatory surgery and specialty pharmacies and has experience with managed care payers, DOD, and the VA in multiple states.


  • Default avatar
    Mario Perez Dolan, Wick Phillips Gould and Martin, LLP
    Default avatar
    David C. Walters, P.C.

Previous Investors

  • Default avatar